University of Basel
Basel, Basel BS, CH-4031, Switzerland
NCT Number: NCT02166567
In assisted reproductive technology (ART) semen needs to be processed. Commonly used methods rely on physical properties of the spermatozoa, such as the swim-up methods and density gradient centrifugation. It is now known that current processing of spermatozoa does not prevent the admixture of spermatozoa with damaged genetic material. The latter have a negative impact on the outcome of ART. The investigators developed a new method for the processing of spermatozoa with intact genetic material based on flow cytometry and sorting (FACS) and on staining using a deye, YoPro. The investigators aim at examining the effect of this novel method of sperm sorting on the outcome of ART.
Looking for future studies?
Notify Me22 year–39 year
All sexes
Interventional
Not applicable
Basel, Basel BS, CH-4031, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: YoPro, FACS
Semen processing will be carried out with the conventional swim-up method.
Time frame: Week 12 of gestation
Time frame: one day after intracytoplasmic sperm injection
Time frame: 5 days after intracytoplasmic sperm injection
Time frame: week 12 of gestation
University Hospital, Basel, Switzerland
Other
The Effect of Sorting of Non-apoptotic and Apoptotic Spermatozoa Using Flow Cytometry on the Outcome of Intracytoplasmic Sperm Injection.
Acronym: Spermsorting
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07669402
Genital Diseases, Genital Diseases, Male
Tehran, Iran
View Trial DetailsNCT02006446
Aneuploidy, Chromosome Aberrations
Lille, France
View Trial DetailsNCT01407484
Cytopenia, Genital Diseases
Paris, France
View Trial DetailsNCT05503862
Genital Diseases, Genital Diseases, Male
Chicago, Illinois, United States
View Trial Details